Can Opioid-Free anesthesia improve surgery recovery?

NCT ID NCT06476600

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jul 08, 2026 · Last updated Jul 09, 2026 · Updated 1 time

Summary

This trial tests whether avoiding opioids during anesthesia leads to better recovery after gallbladder surgery. Half of the participants receive standard opioid-based anesthesia, while the other half receive an opioid-free approach using dexmedetomidine. The study measures recovery quality using a patient questionnaire and tracks heart rate and blood pressure during surgery. It includes adults aged 18-65 with low surgical risk.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Dexmedetomidine and Nalbuphine
What this could lead to
If successful, this could show that opioid-free anesthesia provides similar or better recovery without the risks of opioids.
What could go wrong
This is a small, early-phase trial with only 42 participants, so results may not apply broadly. Dexmedetomidine can cause side effects like low heart rate or blood pressure.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

42 people

The number who actually took part.

Started

Jul 2024

Finished

Oct 2024

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 to 65 years

Sex

Anyone

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: 1. Signed informed consent from the participant. 2. All patients who are aged between 18 - 65 years. 3. American Society of Anaesthesiologists (ASA) classification of I and II 4. Elective Laparoscopic cholecystectomies. Exclusion Criteria: 1. American Society of Anaesthesiologists (ASA) classification of III and above 2. Non-elective surgery 3. Body Mass Index \> 35 4. Patients with regular prescription of Beta-blockers 5. Pregnant or breastfeeding women 6. Allergy to Opioids and/or other drugs used in the trial. 7. Chronic use of opioids or benzodiazepines 8. Chronic pain patients 9. Patients with cardiovascular, renal, hepatic or central nervous system diseases 10. Patients with psychiatric illness

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Laparoscopic cholecystectomy are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Dow university hospital, Dow university of health sciences

    Karachi, Sindh, Pakistan

More trials for these conditions

Other studies related to the condition(s) this trial covers.